BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee OJ, Luk F, Korevaar SS, Koch TG, Baan CC, Merino A, Hoogduijn MJ. The Importance of Dosing, Timing, and (in)Activation of Adipose Tissue-Derived Mesenchymal Stromal Cells on Their Immunomodulatory Effects. Stem Cells and Development 2020;29:38-48. [DOI: 10.1089/scd.2019.0225] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Martinez-arroyo O, Ortega A, Forner MJ, Cortes R. Mesenchymal Stem Cell-Derived Extracellular Vesicles as Non-Coding RNA Therapeutic Vehicles in Autoimmune Diseases. Pharmaceutics 2022;14:733. [DOI: 10.3390/pharmaceutics14040733] [Reference Citation Analysis]
2 Galipeau J, Krampera M, Leblanc K, Nolta JA, Phinney DG, Shi Y, Tarte K, Viswanathan S, Martin I. Mesenchymal stromal cell variables influencing clinical potency: the impact of viability, fitness, route of administration and host predisposition. Cytotherapy 2021;23:368-72. [PMID: 33714704 DOI: 10.1016/j.jcyt.2020.11.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Wong SW, Lenzini S, Giovanni R, Knowles K, Shin JW. Matrix biophysical cues direct mesenchymal stromal cell functions in immunity. Acta Biomater 2021;133:126-38. [PMID: 34365041 DOI: 10.1016/j.actbio.2021.07.075] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 Lee OJ, Koch TG. Steps Toward Standardized In Vitro Assessment of Immunomodulatory Equine Mesenchymal Stromal Cells Before Clinical Application. Stem Cells Dev 2021. [PMID: 34779250 DOI: 10.1089/scd.2021.0189] [Reference Citation Analysis]
5 Najar M, Merimi M, Faour WH, Lombard CA, Moussa Agha D, Ouhaddi Y, Sokal EM, Lagneaux L, Fahmi H. In Vitro Cellular and Molecular Interplay between Human Foreskin-Derived Mesenchymal Stromal/Stem Cells and the Th17 Cell Pathway. Pharmaceutics 2021;13:1736. [PMID: 34684029 DOI: 10.3390/pharmaceutics13101736] [Reference Citation Analysis]
6 Weiss ARR, Lee O, Eggenhofer E, Geissler E, Korevaar SS, Soeder Y, Schlitt HJ, Geissler EK, Hoogduijn MJ, Dahlke MH. Differential effects of heat-inactivated, secretome-deficient MSC and metabolically active MSC in sepsis and allogenic heart transplantation. Stem Cells 2020;38:797-807. [PMID: 32101344 DOI: 10.1002/stem.3165] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
7 Lopez-Santalla M, Bueren JA, Garin MI. Mesenchymal stem/stromal cell-based therapy for the treatment of rheumatoid arthritis: An update on preclinical studies. EBioMedicine 2021;69:103427. [PMID: 34161884 DOI: 10.1016/j.ebiom.2021.103427] [Reference Citation Analysis]
8 Mazini L, Rochette L, Hamdan Y, Malka G. Skin Immunomodulation during Regeneration: Emerging New Targets. J Pers Med 2021;11:85. [PMID: 33573342 DOI: 10.3390/jpm11020085] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]